GH · Guardant Health, Inc.

0001193125-26-275864

Summary

At the annual meeting on June 17, 2026, shareholders elected directors, ratified the auditor, and did not approve advisory say-on-pay compensation.

Key takeaways

All director nominees were elected; Ian Clark received 70,526,891 for and 37,916,548 withheld.
Ratification of Deloitte & Touche as auditor passed with 115,899,030 votes for.
Say-on-pay proposal was not approved, with 98,236,639 for and 9,905,190 against.
Advisory frequency on say-on-pay received 107,997,996 votes for one year.
Broker non-votes totaled 7,714,711 on director and say-on-pay proposals.

Full analysis

The annual meeting results show strong support for the auditor ratification but dissent on executive compensation. The say-on-pay proposal failed to receive majority approval, indicating shareholder concerns about pay practices. Although advisory and non-binding, this outcome may prompt the board to engage with shareholders on compensation issues. The frequency vote favored annual advisory votes, suggesting investors want regular input.